Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
Conditions
- Stage IV Non-small Cell Lung Cancer
- Extensive-stage Small Cell Lung Cancer
- Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC
Interventions
- OTHER: eHealth system support for symptom management via CANKADO
Sponsor
iOMEDICO AG
Collaborators